철 결핍성 빈혈
경희의대 종양혈액내과 조경삼
Erythropoiesis
• RBC production • Hemoglobin =
heme + globin
• Heme = a porphyrin ring + an iron atom
Iron
• Critical element of cell function • Free iron : highly toxic
– Transferrin, ferritin, hemosiderin
• Carry O2 : hemoglobin, myoglobin
• Iron containing enzyme : cytochrome system in mitochodria
• Iron deficiency :
– Decreased Hb synthesis : anemia, hypoxia
Body iron distribution
Iron content (mg) Male(80 kg) Female(60 kg) Hemoglobin 2,500 1,700 Myoglobin/enzyme 500 300 Transferrin iron 3 3 Iron stores 600 – 1,000 0 - 300Iron cycle
• Gain : absorption – diet, medicine
• Loss : the loss of epithelial cells from the skin,
gut, and genitourinary tract blood loss (via
gastrointestinal bleeding, menses, or other forms of bleeding) and
• Male : 1 mg/d ; Female : 1.4 mg/d • RBC : 1 mg/mL
• Daily 0.8 – 1% destruction • Fe turnover : 16 – 20 mg/day
Iron absorption
• Proximal small intestine• Stomach : acidic content
• Gut cell : DMT-1(divalent metal transporter-1) ferritin
---ferroportin (negatively controlled by hepcidin)
• Erythroid hyperplasia : low hepcidin
Hepcidin
• The central regulator of iron absorption, plasma iron levels, and iron distribution
• Hepatocyte, macrophage, adipocyte
• Inhibit iron flows into plasma from macrophage, duodenal enterocyte, hepatocyte
• Bind to the ferroportin (major entryway for iron into plasma) and causing its degradation
• Hepcidin production is regulated by iron and erythropoietic activity
• hepcidin levels are elevated in a range of
inflammatory disease including rheumatologic
diseases, inflammatory bowel disease, a variety of infections, critical illness, and malignancies
Nutritional Iron
• 6 mg/ 1,000 calories • Red meat • M : 6 mg – 15% absorption • F : 11 mg – 12% • Iron deficiency :– meat-containing diet iron : 20% absorption – Vegetarian diet iron : 5 – 10%
Food iron absorption
• Compare to ferrous sulfate• Iron in vegetables : 1/20
• Egg iron : 1/8
• Liver iron : 1/2
Increased iron
requirement
• Infant
• Children
• Adolescent
• Pregnancy : last trimesters : 5-6mg • Increased erythropoiesis
Anemia classification
• Etiologic
– Excessive destruction or loss
• Blood loss : acute, chronic
• Hemolysis – Inadequate production • Nutritional • Marrow failure • Others • Morhologic – Macrocytic : • megaloblastic • nonmegaloblastic – Normochromic normocytic – Hypochromic microcytic
normocytic normochromic
hypochromic microcytic
Iron deficiency anemia
• One of the most prevalent forms of malnutrition
• Globally 50% of anemia • 841,000 deaths annually
• Africa and part of Asia : 71% • North America : 1.4%
Stages of iron deficiency
• Negative iron balance : bloodloss(10-20mL/day), pregnancy, rapid growth spurt, inadequate dietay iron
• Iron-deficient erythropoiesis : microcytic cells, hypochromic
reticulocytes
Absolute iron deficiency
Dietary (growth/development) Women’s health
Pregnancy/breast feeding Menstrual blood losses Chronic blood loss
Blood donation
Nonsteroidal anti-inflammatory drugs (NSAIDs) Gastrointestinal neoplasms
Gastrointestinal parasites (developing countries) Decreased iron absorption
Celiac disease
Helicobacter pylori infection Autoimmune atrophic gastritis
Functional iron deficiency
Iron-sequestration syndromes
Anemia of chronic disease/inflammation Autoimmune diseases
Infections Malignancies
Chronic kidney disease Hepcidin-producing adenomas
Iron refractory iron deficiency anemia (IRIDA) Copper deficiency
Molecular defects in iron transport, recycling, and utilization
Divalent metal transporter 1 (DMT1) mutations Hypotransferrinemia
Ferroportin disease Aceruloplasminemia
Hereditary sideroblastic anemias (ALAS2 mutations) Heme oxygenase deficiency
Clinical presentation of
iron deficiency
• Signs of anemia
– Fatigue – Pallor
– Reduced exercise capacity
• Cheilosis
Laboratory iron studies
• Serum iron(SI) / Total iron-binding capacity(TIBC) :
50-150/300-360 µg/dL (N) • Serum ferritin : < 15 µg/L
• Bone Marrow iron stores : stainable iron, sideroblast, ringed sideroblast (MDS)
• Red cell protoporhyrin levels : > 100 µg/dL
• Soluble transferrin receptor (sTfR) : 4-9 µg/L (N) • Percent hypochromic red cell (% Hypo)
Differential Diagnosis
Hypochromic microcytic
anemia
– Thalassemia
– Anemia of chronic inflammation – Myelodysplastic syndrome
Treatment of
iron-deficiency anemia
• Diet : heme iron • RBC transfusion • Oral iron therapy
• Parenteral iron therapy
– Iron dextran
– Sodium ferric gluconate – Iron sucrose
Amount of iron needed
Ganzoni’s fomula :BW(kg) X 2.3 X (15 – pt’s Hb, g/dL) + 500 or 1,000 mg (for stores)
Parenteral iron therapy
• Unable to tolerate oral iron• Absorbtion defect
• Whose need are relatively acute • Epo therapy
• Iron dextran : severe side effect Sodium ferric gluconate
Iron sucrose
Iron prep. ( 본원 )
• Ferrous sulfate
– Feroba-You : 256 mg (80 mg) / tab
• Iron acetyl-transferrin hydroglycerin – Bolgre Soln : 2 mL (40 mg) / 15 mL
• Iron protein succinylate
– Hemo-Q : 800 mg (40 mg) / 15 mL • Ferric chloride
1st Case 25 세 , 여자 ; 주소 : 창백한 피부 • P.I. : 서서히 시작된 운동시 호흡곤란 , 불규칙한 월경 , 채식 위 주로 식사 • CBC : RBC : 3,200,000/uL, Hb : 7.4 g/dL, Hct : 23% MCV : 72 fL(81-99), MCH : 23.1pg/cell(27-31), MCHC : 32.1 g/dL(33-37) WBC : 8,500/uL, Platelet : 485,000/uL
• Peripheral blood smear : Hypochromic, microcytic, anisocytosis (++), pikilocytosis (+)
• Chemistry : serum Fe : 26 ug/dL, TIBC : 460 ug/dL Ferritin : 15 ng/mL
Normocytic normochromic
Hypochromic microcytic
진단
• Hypochromic, microcytic anemia
– Fe deficience – Inflammation – Thalassemia – Sideroblastic • Fe deficiency anemia – Causes
• 2nd Case : 40 세 , 여자 ; 주소 : 운동시 호흡곤란 P.I. : 서서히 진행 , 창백한 피부 , 잘 부러지는 손톱 , 규칙적이나 양이 많은 월경 • 3rd Case : 58 세 , 여자 ; 주소 : 창백한 피부 P.I. : 서서히 진행되는 운동시 호흡곤란 , 채식위주로 식사 PMH : 5 년전 위암으로 위절제술 , 7 년전 폐 경 • 4th Case : 50 세 , 남자 ; 주소 : 운동시 호흡곤란 P.I. : 서서히 진행 , 식사는 규칙적이고 균형 잡힘 , 특별한 약물 복용 없음 •
진단
• 1st case : blood loss (mense), diet (+),
demend (?)
• 2nd case: blood loss (mense), diet (?),
demend (-): gynecological problem
• 3rd case : blood loss (-), diet (+),
demend (-) : absorption (gastrectomy)
• 4th case : blood loss (?), diet (-),
Treatments of Cases
• 1st Case :• 2nd Case :
• 3rd Case :
만성 질환 빈혈
경희의대 종양혈액내과 조경삼
만성 질환에 수반된 빈혈
(Anemia of Chronic Disorders,ACD)
• 철결핍 빈혈 다음으로 가장 흔한 빈혈이다 . • 기저질환이 호전되어야 빈혈도 호전된다 . • 임상적으로 빈혈의 증상에 기저질환의 다양한 증 상들이 겹쳐서 나타난다 . • 빈혈의 심한 정도는 대개 기저질환의 정도와 비례한다 . • 만성질환 외의 빈혈을 악화시키는 요인이 있 는지 확인이 필요하다 .
Iron-sequestration syndromes
Anemia of chronic disease/inflammation Autoimmune diseases
Infections Malignancies
Chronic kidney disease Hepcidin-producing adenomas
Iron refractory iron deficiency anemia (IRIDA) Copper deficiency
Molecular defects in iron transport, recycling, and utilization
Divalent metal transporter 1 (DMT1) mutations Hypotransferrinemia
Ferroportin disease Aceruloplasminemia
Hereditary sideroblastic anemias (ALAS2 mutations) Heme oxygenase deficiency
Anemia of Chronic
Disorders
• Anemia of Chronic Inflammation • Anemia of Uremia
• Anemia due to Endocrine Failure • Anemia of Liver Disease
Anemia of Chronic Inflammation
• (1) 감염 : 세균심내막염 , 골수염 , 폐농양 , 결핵 , 신우신 염 ( 급성염증 시 1-2 일에 혈색소 2-3g/dL 감소 가능 , 용혈도 관여 ) • (2) 교원성 질환 : 류마티스관절염 ,SLE, 혈관염 (temporalarteritis), sarcoidosis,regional enteritis, tissue injury
• (3) 종양 :HodgkinDisease, 폐암 , 유방암 , 등
( 철결핍 , 골수침윤 , 엽산결핍 , 용혈빈혈 , 약제 , 방사선요법 등에 의한 빈혈 감별 필요 )
임상소견 ( 혈액 소견
)
• 대개 증상 없음 . • 노령에는 증상 나타날 수 있음 .( 심혈관증상 ) • Reti. index 2.0 이하 . • 질환의 기간과 중증도에 비례 • (1) 경도 또는 중등도 ( 혈색소치 9-11g/dL), normocytic or slightly microcytic• (2) 골수소견 : 정상 적혈구 성숙 , 철아구 감소 , 대 식구 내 철 증가
• (3)Reti. 감소 , 혈청철 감소 , transferrin 치 감소 , transferrin saturation : 15-20%, ferritin 은 증가 또는 정상
병태생리
•Ironreutilization 장애로 iron 이
RES 에 sequestration(hepcidin
이 관여
)
•적혈구 수명의 감소 (modest)
•골수의 Epo 반응 감소 , 골수 억제
진단
• Unequivocal diagnosisis often difficult
• Diagnosis of exclusion (infiltration by tumor, fibrosis, or infection, MDS)
• Dx with reticulocyte, Fe, TIBC, serum ferritin, in systemic illness
• R/O nutritional def, hemolysis, sequestration. BM usually not helpful
• DDx of IDA (serum ferritin?, serum transferrin receptor?)
치료
• 철분제재 , 엽산 , 비타민 B12 등의 투여에 반 응 하지 않으나 , 수혈이 필요한 경우는 드뭄 . • 빈혈이 예상보다 심한 경우는 실혈 , 약제에 의한 골수저하 등의 요인이 있는지 조사 . • 만성 출혈로 철결핍 겹친 경우는 철제제 치료에 반응 .• 적응증이 되는 경우 low serum EPO 면 rEPO 사용
Anemia of Uremia
• 대개 azotemia 의 정도에 비례한다 . ( 급성신부전은 비례하지 않는 다 .)
• (BUN > 36mg/dL,Cr3-5mg/dL 면 Hb7g/dL 정도 )
• Polycystic kidney, HUS 때는 적혈구조혈 증가 , 당뇨병에서는 감소
• 정상적혈구 정상색소 빈혈이다 .
• 신장에서 erythropoietin 이 적절히 분비가 되지 않아 빈혈이 발생한 다 .
• 일부 ineffective erythropoiesis, 용혈 , aluminium salt 등이 빈혈의 기전으로 작용한다 .
• 치료 : 신기능의 회복 ( 혈액투석 , 신이식 ), erythropoietin(rhEpo) • 출혈 ( 위장관 , 혈액투석 ), 엽산결핍 ( 혈액투석 , 영양부족 ) 등 다른
Anemia of Hypometabolism:
산소요구량 감소에 의한 적혈구조혈 감소
• Anemia due to Endocrine Failure
– hypothyroidism, Addison'sdisease, hypogonadism, panhypopituitarism, hyperparathyroidism
– Addison'sdisease 치료시 plama volume 감소가 교정되면서 잠시 혈색소
치는 감소하기도 한다.
• Anemia of Liver Disease
– Cholesterol 증가 : Burrcell, stomatocyte – RBC 수명 단축 , 골수 보상 활동 저하
– alcohol: 골수에 독성 , 엽산결핍 , 철결핍 ( 위장관 출혈 , 식이 부족 )
• Anemia of Protein Deprivation:
– volume depletion 으로 masking 가능
• 치료 :
– 수혈 : 증상에 따라 결정 . CV or pulm disease, elderly ,risk of transfusion – Erythropoietin(EPO) w/o iron: 4-6 주에 Hb10-12g/dL 도달 .
– Decreased response: infection, iron del[etion, Al toxicity, hyperparathyroidism